SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MTEN - expected 1000% revenue increase in 97
MTEN 2.490-8.5%1:20 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jonathan D. Fears who wrote (72)2/6/1997 10:25:00 AM
From: Cavior Organization   of 279
 
1)MTEN is very conscious of the importance of insurance companies and is working closely with many of the top ones (e.g. Aetna).

2)MTEN indeed has a second string to its fiddle -- the Steridyne division, acquired last August. Steridyne is running revenues at an annual rate of about $4 million now in digital thermometers and products slotted toward geriatric care in hospitals and nursing homes. For example, its hot new product is a protective sleeve for IV transfusion equipment so that patients continually on IV can bathe and shower without contaminating the transfusion area. Steridyne should grow at least 15 to 20% per year over the next few years. It is a steady source of profitable revenues for MTEN while its glamour product, the PhotoScreener, is ramping up into the black and beyond.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext